JP2008527041A - 有糸分裂キネシン阻害剤 - Google Patents

有糸分裂キネシン阻害剤 Download PDF

Info

Publication number
JP2008527041A
JP2008527041A JP2007552198A JP2007552198A JP2008527041A JP 2008527041 A JP2008527041 A JP 2008527041A JP 2007552198 A JP2007552198 A JP 2007552198A JP 2007552198 A JP2007552198 A JP 2007552198A JP 2008527041 A JP2008527041 A JP 2008527041A
Authority
JP
Japan
Prior art keywords
alkyl
aryl
cycloalkyl
heterocyclyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007552198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008527041A5 (cg-RX-API-DMAC7.html
Inventor
コールマン,ポール・ジエイ
ハートマン,ジヨージ・デイー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JP2008527041A publication Critical patent/JP2008527041A/ja
Publication of JP2008527041A5 publication Critical patent/JP2008527041A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2007552198A 2005-01-19 2006-01-13 有糸分裂キネシン阻害剤 Withdrawn JP2008527041A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64493405P 2005-01-19 2005-01-19
PCT/US2006/001483 WO2006078598A2 (en) 2005-01-19 2006-01-13 Mitotic kinesin inhibitors

Publications (2)

Publication Number Publication Date
JP2008527041A true JP2008527041A (ja) 2008-07-24
JP2008527041A5 JP2008527041A5 (cg-RX-API-DMAC7.html) 2009-02-26

Family

ID=36692770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007552198A Withdrawn JP2008527041A (ja) 2005-01-19 2006-01-13 有糸分裂キネシン阻害剤

Country Status (7)

Country Link
US (1) US20090124641A1 (cg-RX-API-DMAC7.html)
EP (1) EP1855685A4 (cg-RX-API-DMAC7.html)
JP (1) JP2008527041A (cg-RX-API-DMAC7.html)
CN (1) CN101106998A (cg-RX-API-DMAC7.html)
AU (1) AU2006206675A1 (cg-RX-API-DMAC7.html)
CA (1) CA2593166A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006078598A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110171172A1 (en) * 2007-11-07 2011-07-14 Siddiqui M Arshad Compounds for inhibiting ksp kinesin activity
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3964507A1 (en) 2013-10-04 2022-03-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN106456628A (zh) 2014-03-19 2017-02-22 无限药品股份有限公司 用于治疗PI3K‑γ介导的障碍的杂环化合物
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN114230571B (zh) 2015-09-14 2025-07-08 无限药品股份有限公司 异喹啉酮的固体形式、其制备方法、包含其的组合物及其使用方法
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
US10919914B2 (en) 2016-06-08 2021-02-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
CN113549000A (zh) * 2020-04-23 2021-10-26 复旦大学 用于预防或治疗脂质代谢相关疾病的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183931A (en) * 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
US5470975A (en) * 1990-10-16 1995-11-28 E.R. Squibb & Sons, Inc. Dihydropyrimidine derivatives
US6667300B2 (en) * 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
JP2006515886A (ja) * 2003-01-17 2006-06-08 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods

Also Published As

Publication number Publication date
AU2006206675A1 (en) 2006-07-27
EP1855685A4 (en) 2009-12-23
US20090124641A1 (en) 2009-05-14
EP1855685A2 (en) 2007-11-21
CA2593166A1 (en) 2006-07-27
WO2006078598A3 (en) 2007-04-12
WO2006078598A2 (en) 2006-07-27
CN101106998A (zh) 2008-01-16

Similar Documents

Publication Publication Date Title
JP4545196B2 (ja) 有糸分裂キネシン阻害剤
CN101155583B (zh) 有丝分裂驱动蛋白的抑制剂
JP2006516140A (ja) 有糸分裂キネシン阻害剤
JP2008535803A (ja) 有糸分裂キネシン阻害剤
JP2007518711A (ja) 有糸分裂キネシン阻害剤
US20070060601A1 (en) Mitotic kinesin inhibitors
CN101084194A (zh) 有丝分裂驱动蛋白抑制剂
US7595337B2 (en) Mitotic kinesin inhibitors
US7632839B2 (en) Mitotic kinesin inhibitors
US20090124641A1 (en) Mitotic Kinesin Inhibitors
JP2008510013A (ja) 有糸分裂キネシン阻害剤
JP2008505089A (ja) 有糸分裂キネシン阻害剤
CN1980938B (zh) 有丝分裂驱动蛋白抑制剂
JP2008505094A (ja) 有糸分裂キネシン阻害剤
JP2007514757A (ja) 有糸分裂キネシン阻害剤
JP2008510012A (ja) 有糸分裂キネシン阻害剤
JP2008533144A (ja) 有糸分裂キネシン阻害剤
JP2008505090A (ja) 有糸分裂キネシン阻害剤のプロドラッグ
JP2007530545A (ja) 有糸分裂キネシン阻害剤
CN1980663A (zh) 有丝分裂驱动蛋白抑制剂的前体药物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090109

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20101227